Buffer screening made easy for your antibodies. The FORMOscreen® line provides unique and ready-to-use buffers for optimizing antibody stability. All buffers were designed by antibody formulation experts and are proven to be beneficial for stability and storage of therapeutic antibodies. All buffers are approved by the FDA and/or EMA for use in antibody formulations.
Coming soon!
In the meantime, although designed for antibodies, the FORMOscreen® buffer line works great with other proteins, too. Check out our application note below, showing how to improve the formulation of an HIV-vaccine protein!
Coming soon!
We are currently developing special buffer screens for optimizing the formulation of Adenovirus (AV) or Adeno-associated virus (AAV) particles. Stay tuned!
Top sellers
-
FORMOscreen - Antibody Formulation Screen (5x stock)
- Regular price
- €750,00
- Sale price
- €750,00
- Regular price
-
- Unit price
- per
Sold out -
FORMOscreen - Antibody Formulation Screen (1x solutions)
- Regular price
- €750,00
- Sale price
- €750,00
- Regular price
-
- Unit price
- per
Sold out -
FORMOscreen - Antibody Formulation Screen (Single buffer)
- Regular price
- €159,00
- Sale price
- €159,00
- Regular price
-
- Unit price
- per
Sold out -
FORMOscreen - Antibody Formulation Screen (Custom buffers)
- Regular price
- €949,00
- Sale price
- €949,00
- Regular price
-
- Unit price
- per
Sold out
Resources
Multi-parameter formulation development for an HIV-vaccine protein with direct validation of epitope binding integrity and stoichiometry
Vaccines are on the front line-of-defense against infectious diseases, ranging from threats we are familiar with, including polio, tuberculosis, or HIV, to novel and emerging threats such as SARS-CoV-2. Successful development of new protein-based vaccines requires sophisticated and efficient development of storage and formulation conditions. Here we demonstrate the combined power of 2bind’s sophisticated buffer matrix FORMOscreen® and NanoTemper Technologies’ novel Prometheus Panta high-throughput Dynamic Light Scattering/Nano Differential Scanning Fluorimetry instrument. We show that this combination can comprehensively improve critical biophysical parameters for the HIV-1 vaccine BG505-SOSIP and find the optimal formulation condition with unmatched efficiency.
Read on BioRxiv.